Class-Action Lawsuit Filed Against Remdesivir Manufacturer Over Alleged Deceptive Practices
Gilead manufacturing remdesivir, used to treat COVID-19, hit with class-action lawsuit over allegations it deceptively promoted drug without disclosing side effects.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed